Alpha Teknova Inc (TKNO) financials
Alpha Teknova revenue and earnings by year
Alpha Teknova's revenue was $40.5 million in the fiscal year to December 31, 2025, up 7.4% from the year before. Net income was -$17.3 million, -42.6% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 12.4% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 7 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 41 | 38 | 37 | 41 | 37 | 31 | 20 |
| Revenue growth | 7.4% | 2.9% | -11.4% | 12.3% | 17.9% | 55.8% | — |
| Gross profit | 13 | 7 | 10 | 17 | 18 | 18 | 9 |
| Gross margin | 33.2% | 19.2% | 28.1% | 42.2% | 47.8% | 56.7% | 42.7% |
| Operating income | -17 | -26 | -36 | -50 | -12 | 5 | -2 |
| Operating margin | -41.9% | -69.3% | -96.9% | -119.9% | -32.5% | 14.9% | -9.2% |
| Net income | -17 | -27 | -37 | -47 | -10 | 4 | -1 |
| Net margin | -42.6% | -70.9% | -100.3% | -114.6% | -26.6% | 11.4% | -6.5% |
| Diluted EPS | -$0.32 | -$0.57 | -$1.16 | -$1.69 | -$0.61 | — | — |
| Free cash flow | -10 | -13 | -27 | -56 | -29 | -3 | -0 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open TKNO in Markets.
How Alpha Teknova makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Lab Essentials | $9.18M | 75.4% |
| Clinical Solutions | $2.43M | 19.9% |
| Other Product | $573K | 4.7% |
See also: TKNO returns
No forecast, no recommendation. This page describes Alpha Teknova Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.